E-LIB Suche - Ergebnisse für: Yahiro, Kenichiro

1

Nuclear β-catenin translocation plays a key role in osteobl..:

Kimura, Atsushi ; Toda, Yu ; Matsumoto, Yoshihiro...
Scientific Reports. 12 (2022) 1 - p. , 2022

2

Methylation-mediated silencing of protein kinase C zeta ind..:

Shimada, Eijiro ; Matsumoto, Yoshihiro ; Nakagawa, Makoto...
British Journal of Cancer. 126 (2022) 9 - p. 1289-1300 , 2022

Link: https://doi.org/10.1038/..

3

Clinical benefits of vessel sealing system (LigaSure™) duri..:

Shimada, Eijiro ; Matsumoto, Yoshihiro ; Endo, Makoto...
Japanese Journal of Clinical Oncology. 51 (2021) 8 - p. 1242-1247 , 2021

Link: https://doi.org/10.1093/..

4

Activation of TLR4 signaling inhibits progression of osteos..:

Yahiro, Kenichiro ; Matsumoto, Yoshihiro ; Yamada, Hisakata...
Cancer Immunology, Immunotherapy. 69 (2020) 5 - p. 745-758 , 2020

Link: https://doi.org/10.1007/..

5

Selective inhibition of mutant IDH1 by DS-1001b ameliorates..:

Nakagawa, Makoto ; Nakatani, Fumihiko ; Matsunaga, Hironori...
Oncogene. 38 (2019) 42 - p. 6835-6849 , 2019

Link: https://doi.org/10.1038/..

6

Diagnosis and Management of Subcutaneous Soft Tissue Sarcom:

Endo, Makoto ; Setsu, Nokitaka ; Fujiwara, Toshifumi...
Current Treatment Options in Oncology. 20 (2019) 7 - p. , 2019

Link: https://doi.org/10.1007/..

7

Correction: Hypoxia-inducible factor 1 alpha is a poor prog..:

Fukushima, Suguru ; Endo, Makoto ; Matsumoto, Yoshihiro...
PLOS ONE. 13 (2018) 3 - p. e0194508 , 2018

Link: https://doi.org/10.1371/..

8

Class III β-Tubulin Overexpression Induces Chemoresistance ..:

Yahiro, Kenichiro ; Matsumoto, Yoshihiro ; Fukushi, Jun-ichi...
Analytical Cellular Pathology. 2018 (2018) - p. 1-11 , 2018

Link: https://doi.org/10.1155/..

9

Hypoxia-inducible factor 1 alpha is a poor prognostic facto..:

Fukushima, Suguru ; Endo, Makoto ; Matsumoto, Yoshihiro...
PLOS ONE. 12 (2017) 5 - p. e0178064 , 2017

Link: https://doi.org/10.1371/..

10

Methylation-mediated silencing of protein kinase C zeta ind..:

Shimada, Eijiro ; Matsumoto, Yoshihiro ; Nakagawa, Makoto...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042856/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Immunotherapy for osteosarcoma:

Yahiro, Kenichiro ; Matsumoto, Yoshihiro
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078647/. , 2020

Link: http://www.ncbi.nlm.nih...

12

Nuclear β-catenin translocation plays a key role in osteobl..:

Atsushi Kimura ; Yu Toda ; Yoshihiro Matsumoto...
https://doi.org/10.1038/s41598-022-17728-5. , 2022

Link: https://doi.org/10.1038/..

13

Immunotherapy for osteosarcoma:

Kenichiro Yahiro ; Yoshihiro Matsumoto
http://dx.doi.org/10.1080/21645515.2020.1824499. , 2021

Link: https://doi.org/10.1080/..

14

Class III β-Tubulin Overexpression Induces Chemoresistance ..:

Kenichiro Yahiro ; Yoshihiro Matsumoto ; Jun-ichi Fukushi...
http://dx.doi.org/10.1155/2018/8987568. , 2018

Link: https://doi.org/10.1155/..

15

Correction: Hypoxia-inducible factor 1 alpha is a poor prog..:

Suguru Fukushima ; Makoto Endo ; Yoshihiro Matsumoto...
http://europepmc.org/articles/PMC5854433?pdf=render. , 2018

Link: https://doi.org/10.1371/..